This Article Full Text Full Text (PDF) All Versions of this Article: 92/4/1564    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Costa-Guda, J. Articles by Arnold, A. Search for Related Content PubMed PubMed Citation Articles by Costa-Guda, J. Articles by Arnold, A. Related Collections Calcium and Bone Metabolism Endocrine Oncology

Absence of Stabilizing Mutations of ß-Catenin Encoded by CTNNB1 Exon 3 in a Large Series of Sporadic Parathyroid Adenomas

Center for Molecular Medicine and Division of Endocrinology and Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut 06030

Address all correspondence and requests for reprints to: Dr. Andrew Arnold, Center for Molecular Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030-3101. E-mail: molecularmedicine{at}uchc.edu.

Context: The molecular mechanisms underlying the pathogenesis of sporadic parathyroid adenomas are incompletely understood. Dysfunction of the Wnt signaling pathway is an established pathogenetic contributor to human tumorigenesis and, recently, the role of stabilizing mutations in ß-catenin, a cause of abnormal Wnt signaling, has been examined in parathyroid tumors with conflicting results.

Objective: The objective of the present study was to determine the frequency of stabilizing mutations in exon 3 of CTNNB1, encoding ß-catenin, in a large series of parathyroid adenomas.

Patients and Design: Ninety-seven sporadic parathyroid adenomas were examined for mutations in exon 3 of CTNNB1 by direct DNA sequencing.

Results: No mutations were identified in any of the adenomas.

Conclusions: The absence of stabilizing mutations of ß-catenin, including the previously reported S37A, encoded in CTNNB1 exon 3 among 97 tumors suggests that such mutations contribute rarely if at all to the development of sporadic parathyroid adenomas. A primary role for abnormal Wnt signaling in parathyroid tumor formation remains to be established.

This article has been cited by other articles:

				W. F. Simonds Ruling Out a Suspect: the Role of {beta}-Catenin Mutation in Benign Parathyroid Neoplasia J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1235 - 1236. [Full Text] [PDF]